JPRN-jRCT1080222429已完成未知
36-month Special Drug Use Surveillance on Frequency of Bone Fractures with Benet 75 mg Tablets
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 579
研究概览
简要总结
In conclusion, no new problem of Benet was detected in terms of the safety or efficacy in clinical settings. In addition, as high as 83.24% to 95.38% of patients took the drug as instructed by a physician from the start of Benet treatment to the 36th dose (3 years), and the median dosing interval between two consecutive doses was 30.0 to 31.0 days, showing a good treatment status. Refer to summary of the special drug use surveillance in "Secondary Outcome Measures" section for others.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 50age old 至 ot applicable(—)
- 性别
- All
入选标准
- •Osteoporosis patients who meet all the following criteria:
- •1. Patients with 1 to 4 confirmed vertebral body fractures in the T4-L4 region by thoracic and lumbar spine X-ray examination at screening (within 3 months before the start of administration of sodium risedronate 75 mg tablets)
- •2. Male and postmenopausal female patients aged 50 years or older
- •3. Ambulatory outpatients
排除标准
- 未提供
研究者
相似试验
已完成
Unknown
Special Drug Use Surveillance of Vonoprazan for Maintenance Therapy of Reflux Esophagitis: Long-term UseJPRN-jRCT1080223147Takeda Pharmaceutical Company Limited1,237
已完成
Unknown
Special drug use surveillance of Vonoprazan for prevention of recurrence of gastric/duodenal ulcer in patients receiving low-dose aspirin: long-term useGastric or duodenal ulcersJPRN-jRCT1080223380Takeda Pharmaceutical Company Limited1,119
招募中
不适用
Special Drug Use Results Surveillance for the use of Odefsey in pregnant womeHIV/AIDSJPRN-UMIN000034028Janssen Pharmaceutical K.K.3
已完成
Unknown
The special drug use surveillance of INAVIR for inhalation suspension set (Safety evaluation in pediatric patients under five years old)Influenza virus infectionJPRN-jRCT1080224937DAIICHI SANKYO CO., LTD.1,156
已完成
Unknown
Drug Use Surveillance of Vonoprazan for Gastric Ulcer, Duodenal Ulcer, and Reflux EsophagitisGastric ulcer, duodenal ulcer, and reflux esophagitisJPRN-jRCT1080223122Takeda Pharmaceutical Company Limited3,183
